Type to search

Amgen to Acquire Chemocentryx for $4 Billion in Cash | Pharmtech Focus
Hundreds of Patients to Benefit From Revolutionary Lung Cancer Drug On The NHS | Pharmtech Focus
Owkin and Amgen Use AI to Improve Cardiovascular Risk Prediction | Pharmtech Focus